NIKE INC -CL B (NKE) 105.96 -0.69 (-0.65%)
105.96 -0.69 (-0.65%)
US6541061031 - Common Stock - After market: 105.96 0 (0%)
Fundamental Rating
Overall NKE gets a fundamental rating of 5 out of 10. We evaluated NKE against 49 industry peers in the Textiles, Apparel & Luxury Goods industry. NKE scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NKE is quite expensive at the moment. It does show a decent growth rate.
Profitability
Profitability Rating
NKE's Return On Assets of 13.73% is amongst the best returns of the industry. NKE outperforms 83% of its industry peers. The industry average Return On Assets is 4.94%.
NKE's Return On Equity of 35.65% is amongst the best of the industry. NKE does better than the industry average Return On Equity of 23.41%.
NKE's Profit Margin of 11.96% is amongst the best returns of the industry. NKE outperforms 81% of its industry peers. The industry average Profit Margin is 5.39%.
The Piotroski-F score of NKE is 5.00. This is a neutral score and indicates average health and profitability for NKE.
VS Industry
ROA (13.73%) VS Industry: 83% outperformed.
-114.87
22.39
ROE (35.65%) VS Industry: 78% outperformed.
0.20
114.27
Profit Margin (11.96%) VS Industry: 81% outperformed.
-184.15
19.11
Valuation
Valuation Rating
With a price book ratio of 10.48, NKE is valued correctly.
With a Price/Earnings Ratio of 30.02, NKE can be considered very expensive at the moment.
With a Price/Earning Ratio of 30.02, NKE is valued a higher than the industry average, which is at 11.00. 89% of the companies listed in the same industry are cheaper than NKE!
The Forward Price/Earnings Ratio of 27.69 indicates a quite expensive current valuation of NKE.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
When comparing the price book ratio of NKE to the average industry price book ratio of 2.12, NKE is valued more expensive than its industry peers. 96% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of NKE to the average industry ratio of 7.80, NKE is valued more expensive than its industry peers. 91% of the companies listed in the same industry are valued cheaper.
VS Industry
Price/Earnings (30.02) VS Industry: 11% outperformed.
267.50
4.85
Price/Book (10.48) VS Industry: 4% outperformed.
16.11
0.08
Enterprise Value/ EBITDA (22.42) VS Industry: 9% outperformed.
283.08
3.20
Growth
Growth Rating
The Earnings Per Share is expected to grow by 13.41% on average over the next 5 years. This is quite good.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
NKE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.37%.
Measured over the past 5 years, NKE shows a small growth in Earnings Per Share. The EPS has been growing by 8.42% on average per year.
Looking at the last year, NKE shows a small growth in Revenue. The Revenue has grown by 2.07% in the last year.
Measured over the past 5 years, NKE shows a small growth in Revenue. The Revenue has been growing by 6.34% on average per year.
Based on estimates for the next 5 years, NKE will show a small growth in Revenue. The Revenue will grow by 5.38% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | 8.42% | 14.73% | -6.37% | -20.15% | 0.88% | 7.14% | 13.41% |
| Revenue | 6.34% | 6.09% | 2.07% | 4.96% | 6.55% | 7.36% | 5.38% |
Health
Health Rating
A Current Ratio of 2.64 indicates that NKE has no problem at all paying its short term obligations.
NKE is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.34.
The Quick Ratio of NKE is much better than the industry average of 1.14.
An Altman-Z score of 6.23 indicates that NKE is not in any danger for bankruptcy at the moment.
NKE has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.89. NKE has a better score than 89% of its industry peers.
NKE has a Quick Ratio of 1.76. This is a normal value and indicates that NKE is financially healthy and should not expect problems in meeting its short term obligations.
The Piotroski-F score of NKE is 5.00. This is a neutral score and indicates average health and profitability for NKE.
Compared to an average industry Debt to Equity Ratio of 0.37, NKE is more dependent on financing than its industry peers.
VS Industry
Debt/Equity (0.56) VS Industry: 38% outperformed.
5.42
0.00
Quick Ratio (1.76) VS Industry: 77% outperformed.
0.06
4.17
Current Ratio (2.64) VS Industry: 68% outperformed.
0.38
7.90
Altman-Z (6.23) VS Industry: 89% outperformed.
-67.52
16.89
Dividend
Dividend Rating
The dividend of NKE is nicely growing with an annual growth rate of 11.36%!
NKE pays out 33.37% of its income as dividend. This is a sustainable payout ratio.
NKE has been paying a dividend for at least 10 years, so it has a reliable track record.
NKE has a Yearly Dividend Yield of 1.29%.
Compared to an average industry Dividend Yield of 3.43, NKE's dividend is way lower than its industry peers. On top of this 96% of the companies listed in the same industry pay a better dividend than NKE!
Compared to an average S&P500 Dividend Yield of 2.47, NKE's dividend is way lower than the S&P500 average.
NKE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
VS Industry
Dividend Yield (1.29%) VS Industry: 4% outperformed.
0.25
8.88
NIKE INC -CL B105.96
NYSE:NKE (11/25/2022, 7:17:51 PM)-0.69 (-0.65%)
| GICS Sector | Consumer Discretionary | ||
| GICS IndustryGroup | Consumer Durables & Apparel | ||
| GICS Industry | Textiles, Apparel & Luxury Goods | ||
| Earnings (Last) | 09-29 2022-09-29/amc | Earnings (Next) | 12-20 2022-12-20/amc |
| Ins Owners | 0.14% | Inst Owners | 146.23% |
| Market Cap | 165.79B | Analysts | 76.67 |
| PE | 30.02 | Fwd PE | 27.69 |
| PEG (NY) | N/A | PEG (5Y) | 3.57 |
| P/S | 3.52 | P/B | 10.48 |
| EV/EBITDA | 22.42 | ||
| Dividend Yield | 1.29% | Dividend Growth | 11.36% |
| DP | 33.37% | Ex-Date | 12-02 2022-12-02 (0.34) |
| EPS 1Y | -6.37% | EPS 3Y | 14.73% |
| EPS 5Y | 8.42% | EPS growth Q2Q | -19.83% |
| EPS Next Y | -20.15% | EPS Next 2Y | 0.88% |
| EPS Next 3Y | 7.14% | EPS Next 5Y | 13.41% |
| Revenue growth 1Y | 2.07% | Revenue growth 3Y | 6.09% |
| Revenue growth 5Y | 6.34% | Revenue growth Q2Q | 3.58% |
| Revenue Next Year | 4.96% | Revenue Next 2Y | 6.55% |
| Revenue Next 3Y | 7.36% | Revenue Next 5Y | 5.38% |
| Current Ratio | 2.64 | Quick Ratio | 1.76 |
| Altman-Z | 6.23 | F-Score | 5 |
| Debt/Equity | 0.56 | WACC | 9.72% |
| ROIC/WACC | 3.21 | ||
| ROA | 13.73% | ROE | 35.65% |
| ROICexgc | 31.14% | ROIC | 18.3% |
| PM | 11.96% | OM | 13.25% |
| Asset Turnover | 1.15 | ||
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA